Amicus Therapeutics – A Biopharmaceutical Firm Based in New Jersey

Amicus Therapeutics is a biopharmaceutical firm based in New Jersey, America. The firm went public in 2007 under the trading name, NASDAQ (Google Finance). The establishment of Amicus Therapeutics was financed by selected capital venture firms such as Radius Venture, New Enterprise Associates, and Canaan Partners. The organization focuses on the treatment of rare and orphan diseases, more so lysosomal storage disorders. The product development of the company is primarily based on CHART (Chaperone-Advanced Replacement Therapy), as well as enzyme replacement therapies.
In 2014, Amicus Therapeutics was noted as one of the companies that have the broadest portfolio of pharmacological chaperones small molecule in the pharmaceutical industry. Moreover, Amicus Therapeutics has a robust development pipeline for the treatment of various human genetic disease. For example, Amicus Therapeutics has a lead product known as migalastat. The product is a personalized medicine that is used for treating people with Fabry disease. Amicus Therapeutics is also working in collaboration with JCR Pharmaceutical and GlaxoSmithKline to explore coformulation with the recombinant alpha-galactosidase. However, the collaboration lasted for only three years.
Amicus does not have the manufacturing capability to produce its products. It relies on contracts from other companies for the manufacturing process. However, in 2008, the company expanded its operation. Apart from the normal research site in New Jersey, Amicus Therapeutics also has another research site in San Diego. Since its establishment, Amicus has been on the good side of the business. In 2010, Amicus Therapeutics received a grant worth $500000 from Michael Joseph Fox Foundation. The grant was meant to support the research study that was being conducted by Amicus in partnership with David Geffen Medical School. The company also received another grant worth $210300 from ADDF (Alzheimer’s Drug Discovery Foundation). Amicus Therapeutics used the grant to support its pre-clinical work. Also, in 2013, Amicus was able to have the necessary intellectual property and proprietary materials for the treatment of Pompe infection.

For more information visit: https://www.crunchbase.com/organization/amicus-therapeutics

| Twitter

 

The Luxurious Lifestyle of Magnises Members & Billy McFarland

Magnises was founded in 2014 by Billy McFarland. Magnises is a private club that professionals can join that will give them access to private events on the East Coast. Magnises gives their members a card and they offer various opportunities to their members. These cards help professionals access exclusive clubs on the East Coast as well as getting them deals on hotels and more. The prices of these cards vary depending on what you’re looking for, but they are relatively inexpensive. Magnises continues to add new perks for their members frequently.

Magnises is not only about perks and deals. Magnises is also about helping young professionals build a network. Magnises holds events along the East Coast to bring these young professionals together in a relaxed setting. Magnises is dedicated to helping professionals find each other and to expand their opportunities.

Billy McFarland is Magnises’ founder. Billy McFarland is the founder of several other businesses in the United States at the young age of 25 years old. Billy McFarland is a successful business man so far and he continues to strive to remain that way.

When Billy McFarland had been just 13 years old, he founded his very first company. After Billy McFarland graduated from high school, he attended Bucknell University for a little while which is located in Lewisburg, Pennsylvania, where he studied computer engineering.

Read more:
Magnises Is The Black Card That Helps Millennials Build The Best Network
Carded: What It’s Like to Own a Magnises Card

After Billy McFarland dropped out of computer engineering at the college, he founded another business in 2010 and then various businesses afterwards. Magnises has been the most successful business that he has founded. Magnises already has over thirty thousand members and that number continues to grow everyday. Magnises is gaining exposure all over the United States and the company has already collected millions of dollars since they have been operating.

Billy McFarland has been dedicated to help people find each other using Magnises. Magnises holds events that often help young professionals come together in hopes of finding new business opportunities. Magnises holds a variety of events depending on what events young professionals would be interested in participating.

Magnises continues to grow and they continue to add more and more perks often. The most recent perks have been discounted hotel rates and access to exclusive clubs on the East Coast. Magnises wants to help young professionals by offering them deals at luxurious hotels along the East Coast. These hotels that would be expensive without the pass, are very inexpensive if you are a member of Magnises. Magnises offers the most luxurious hotels with a luxurious price tag.

Magnises has a growing presence on social media. Magnises currently has an Instagram and Facebook account that they update frequently to show new members what they offer. These social media accounts explain their events with pictures of the places that they are holding these events. Magnises has just recently opened up in San Francisco. Magnises has been using social media to showcase what they offer in various cities across the United States.

Magnises is definitely the way to go if you’re a professional looking for a social network. Magnises offers a luxurious lifestyle after you become a member and it’s well worth it!

Like Magnises on Facebook